News und Analysen

With the stock market recently hitting new all-time highs again, times are exciting for people who are fully invested, but these conditions can be more frustrating for those who have cash available

Dividend Kings are unquestionably among the top picks for income-seeking investors. These are companies that have increased their payouts for at least 50 consecutive years, which strongly suggests

UnitedHealth Group (NYSE: UNH) is one of the largest healthcare companies in the world. Its market cap sits at around $470 billion. And this is a stock that has risen tremendously in value. In the

Any time is a good time to buy solid dividend stocks. But this month is a special time to do so for one simple reason: There's an extra day for investors to buy stocks because it's a leap year.

Medical device maker Medtronic (NYSE: MDT) offers investors a couple of ways to build wealth: through the stock's gains and through its dividend income. Over the past decade, the stock has risen by

Abbott Laboratories (NYSE: ABT) is a diversified health care company that gives investors a great deal of stability. Between testing, nutritional products, pharmaceuticals, and medical devices, the

Vertex Pharmaceuticals (NASDAQ: VRTX) already brings in billions of dollars annually, thanks to its cystic fibrosis (CF) drugs. The company recently proved it could expand beyond the specialty area

Image source: The Motley Fool.

AbbVie (NYSE: ABBV)Q4 2023 Earnings CallFeb 02, 2024, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q4 2023 Earnings CallFeb 02, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Drugmakers Novo Nordisk and Eli Lilly have been making headlines in recent times, thanks to their sought-after weight loss drugs. In fact, the products have become so popular that demand has

Some of the best dividend stocks don't have the best yields -- yet. And that's because their businesses are still experiencing some strong growth and they have to set some cash aside to help fund

The biotech industry has been in a slump over the past two years, but Amgen (NASDAQ: AMGN) has performed comparatively well. That's not to say this leading drugmaker hasn't had its share of issues

Pfizer (NYSE: PFE) celebrates its 175th anniversary this year, so the pharma giant has a long history. But the drugmaker actually jumped into the global spotlight not long ago when it launched its

Good news from the lab sparked a mini-rally in Vertex Pharmaceuticals (NASDAQ: VRTX) stock on Tuesday. The biotech's shares closed the trading session more than 2% higher in price, which was good

Image source: The Motley Fool.

Pfizer (NYSE: PFE)Q4 2023 Earnings CallJan 30, 2024, 10:00 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Pfizer (NYSE: PFE) jumped as much as 3.2% higher on Tuesday morning before giving up all of the gains and then some. The pharma stock was down by 0.6% as of 12:05 p.m. ET.

These gyrations

As dividend investors know, there's an upside to investing in a big pharmaceutical business like Amgen (NASDAQ: AMGN) for dividend income. It likely has the resources and proven capabilities that'll

Famed investor Warren Buffett once said he aimed to be greedy when others were fearful. Here's one way to apply this bit of advice when investing in stocks: Equities that look beaten-down can be

Microsoft, Apple, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla -- a group that Bank of America analyst Michael Hartnett dubbed the "Magnificent Seven," -- have taken the market by storm for

What's the appeal of investing in relatively small and little-known corporations? Though these businesses come with heightened risks, getting in on the ground floor can potentially be lucrative over

Pfizer (NYSE: PFE) has reached a major transition point. The big pharma company took center stage earlier in the COVID-19 pandemic when it became the first to launch a coronavirus vaccine. That

I'll readily admit that I've picked some supposed growth stocks in the past that didn't deliver much growth. The good news, though, is that my winners have far outpaced my losers over the long run.

UnitedHealth Group (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ) are two of the largest healthcare companies in the world. One is focused on health insurance, while the other makes medical devices

Cancer bites, but Amgen (NASDAQ: AMGN) is going to keep biting back. In fact, it's currently developing a handful of oncology medicines that it describes as bispecific T-cell engager therapies, or

Time in the market beats timing the market, hands-down. But how long should you own a stock?

Famed investor Warren Buffett perhaps said it best: "When we own portions of outstanding businesses with